MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 45 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $362,799 | -37.3% | 2,291,286 | +7.3% | 0.00% | – |
Q1 2024 | $578,856 | +69.8% | 2,135,457 | +35.5% | 0.00% | – |
Q4 2023 | $340,950 | +33.7% | 1,576,513 | -19.6% | 0.00% | – |
Q3 2023 | $254,935 | -63.9% | 1,960,492 | +0.1% | 0.00% | – |
Q2 2023 | $705,222 | -16.9% | 1,958,952 | +8.5% | 0.00% | – |
Q1 2023 | $848,283 | +93944.7% | 1,804,858 | 0.0% | 0.00% | – |
Q4 2022 | $902 | -99.9% | 1,804,858 | +6.8% | 0.00% | – |
Q3 2022 | $1,074,000 | -12.3% | 1,690,196 | +9.0% | 0.00% | – |
Q2 2022 | $1,225,000 | -6.6% | 1,551,186 | -4.9% | 0.00% | – |
Q1 2022 | $1,311,000 | -18.2% | 1,630,677 | +2.8% | 0.00% | – |
Q4 2021 | $1,602,000 | -11.6% | 1,586,863 | +13.8% | 0.00% | – |
Q3 2021 | $1,813,000 | +77.4% | 1,394,744 | +5.7% | 0.00% | – |
Q2 2021 | $1,022,000 | -23.1% | 1,318,959 | +4.2% | 0.00% | – |
Q1 2021 | $1,329,000 | -12.9% | 1,265,916 | +12.9% | 0.00% | – |
Q4 2020 | $1,525,000 | +84.6% | 1,121,331 | +3.9% | 0.00% | – |
Q3 2020 | $826,000 | -1.0% | 1,079,415 | 0.0% | 0.00% | – |
Q2 2020 | $834,000 | +28.9% | 1,079,415 | 0.0% | 0.00% | – |
Q1 2020 | $647,000 | -83.6% | 1,079,415 | -37.9% | 0.00% | – |
Q4 2019 | $3,944,000 | +677.9% | 1,737,624 | +115.9% | 0.00% | – |
Q3 2019 | $507,000 | -13.2% | 804,690 | +17.9% | 0.00% | – |
Q2 2019 | $584,000 | -21.4% | 682,332 | 0.0% | 0.00% | – |
Q1 2019 | $743,000 | +53.5% | 682,332 | -16.1% | 0.00% | – |
Q4 2018 | $484,000 | +29.4% | 813,466 | +100.0% | 0.00% | – |
Q3 2018 | $374,000 | +111.3% | 406,733 | -0.5% | 0.00% | – |
Q2 2018 | $177,000 | -57.3% | 408,605 | -24.9% | 0.00% | – |
Q1 2018 | $415,000 | -32.3% | 543,804 | +2.8% | 0.00% | – |
Q4 2017 | $613,000 | -7.4% | 529,177 | +5.5% | 0.00% | – |
Q3 2017 | $662,000 | -20.8% | 501,565 | +1.3% | 0.00% | – |
Q2 2017 | $836,000 | – | 495,222 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 10,188,312 | $8,727,000 | 0.75% |
Vivo Capital, LLC | 6,818,181 | $5,840,000 | 0.55% |
Stonepine Capital Management, LLC | 668,615 | $573,000 | 0.40% |
Telemetry Investments, L.L.C. | 574,619 | $492,000 | 0.38% |
Broadfin Capital, LLC | 766,708 | $657,000 | 0.14% |
Granite Point Capital Management, L.P. | 1,500,000 | $1,285,000 | 0.09% |
STALEY CAPITAL ADVISERS INC | 200,000 | $171,000 | 0.01% |
HYMAN CHARLES D | 79,800 | $68,000 | 0.01% |
CRA Financial Services, LLC | 10,000 | $9,000 | 0.01% |
BRIGHTON JONES LLC | 50,000 | $43,000 | 0.01% |